Safety and immunogenicity of bk-se36 in a blinded, randomized, controlled, age de-escalating phase ib clinical trial in burkinabe children
HIGHLIGHTS who: Edith Christiane Bougouma from the RenéRachou Institute (FIOCRUZ), Brazil Diseases, Osaka University, Suita have published the article: Safety […]